2019
DOI: 10.1016/j.rvsc.2019.07.009
|View full text |Cite
|
Sign up to set email alerts
|

CSF omeprazole concentration and albumin quotient following high dose intravenous omeprazole in dogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 37 publications
0
1
0
Order By: Relevance
“…The principle is that these drugs reduce CSF production thus reducing the driving force contributing to CM-P and SM. However, studies assessing the effect of omeprazole on CSF production by evaluating the albumen quotient (QAlb; ratio between CSF and serum albumin concentration) did not support a CSF-reducing effect (Girod and others 2016), although the validity of QAlb as a surrogate marker for CSF production was later disputed (Girod and others 2019). More importantly, omeprazole may not achieve a therapeutic choroid plexus concentration, so the effect, if any, of antacids on CSF production remains unsubstantiated.…”
Section: Medical Managementmentioning
confidence: 99%
“…The principle is that these drugs reduce CSF production thus reducing the driving force contributing to CM-P and SM. However, studies assessing the effect of omeprazole on CSF production by evaluating the albumen quotient (QAlb; ratio between CSF and serum albumin concentration) did not support a CSF-reducing effect (Girod and others 2016), although the validity of QAlb as a surrogate marker for CSF production was later disputed (Girod and others 2019). More importantly, omeprazole may not achieve a therapeutic choroid plexus concentration, so the effect, if any, of antacids on CSF production remains unsubstantiated.…”
Section: Medical Managementmentioning
confidence: 99%